Skip to main content

ADVERTISEMENT

Noncolorectal

Videos
04/03/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the standard first-line therapies available for pancreatic cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed the standard first-line therapies available for pancreatic cancer.
At the 2019 Great Debates &...
04/03/2019
Oncology
Videos
03/30/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed using second-line PRRT in patients with pNETs.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Berlin discussed using second-line PRRT in patients with pNETs.
At the 2019 Great Debates &...
03/30/2019
Oncology
Videos
03/29/2019
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Ilson discussed factors to consider when treating patients with esophageal cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Dr Ilson discussed factors to consider when treating patients with esophageal cancer.
At the 2019 Great Debates &...
03/29/2019
Oncology
Videos
08/01/2018
Josep Tabernero, MD, PhD, summarizes the overall survival results from the TAGS study of trifluridine/tipiracil vs placebo in patients with metastatic gastric cancer refractory to standard therapies.
Josep Tabernero, MD, PhD, summarizes the overall survival results from the TAGS study of trifluridine/tipiracil vs placebo in patients with metastatic gastric cancer refractory to standard therapies.
Josep Tabernero, MD, PhD,...
08/01/2018
Oncology
Videos
07/10/2018
Eileen M O'Reilly, MD, discusses the value of using biomarkers to guide treatment selection for patients with pancreatic cancer.
Eileen M O'Reilly, MD, discusses the value of using biomarkers to guide treatment selection for patients with pancreatic cancer.
Eileen M O'Reilly, MD, discusses...
07/10/2018
Oncology
Videos
07/10/2018
Eileen M O'Reilly, MD, discusses the current landscape of immunotherapies for pancreatic cancer.
Eileen M O'Reilly, MD, discusses the current landscape of immunotherapies for pancreatic cancer.
Eileen M O'Reilly, MD, discusses...
07/10/2018
Oncology
Videos
07/10/2018
Thierry Conroy, MD, discusses the current evidence supporting adjuvant therapy for patients with pancreatic cancer, the anticipated impact of a new trial presented supporting mFOLFIRINOX for adjuvant therapy in resected patients, and how...
Thierry Conroy, MD, discusses the current evidence supporting adjuvant therapy for patients with pancreatic cancer, the anticipated impact of a new trial presented supporting mFOLFIRINOX for adjuvant therapy in resected patients, and how...
Thierry Conroy, MD, discusses...
07/10/2018
Oncology
Videos
07/10/2018
Ghassan K Abou-Alfa, MD, shares his thoughts on a presentation given by Andrew X Zhu, MD, at the 2018 ESMO World Congress on Gastrointestinal Cancer on REACH and REACH-2 clinical trial data for ramucirumab as treatment in hepatocellular...
Ghassan K Abou-Alfa, MD, shares his thoughts on a presentation given by Andrew X Zhu, MD, at the 2018 ESMO World Congress on Gastrointestinal Cancer on REACH and REACH-2 clinical trial data for ramucirumab as treatment in hepatocellular...
Ghassan K Abou-Alfa, MD, shares...
07/10/2018
Oncology
Videos
07/10/2018
Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses the biggest challenges that remain for the treatment of hepatocellular carcinoma. 
Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses the biggest challenges that remain for the treatment of hepatocellular carcinoma. 
Ghassan K Abou-Alfa, MD, medical...
07/10/2018
Oncology
Videos
07/10/2018
Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses a few of the newer agents available for the treatment of hepatocellular carcinoma, and how these agents have impacted practice.
Ghassan K Abou-Alfa, MD, medical oncologist at the Memorial Sloan Kettering Cancer Center (New York, NY), discusses a few of the newer agents available for the treatment of hepatocellular carcinoma, and how these agents have impacted practice.
Ghassan K Abou-Alfa, MD, medical...
07/10/2018
Oncology